Relationship between Antidepressant Prescription Rates and Features of Schizophrenic Patients and Its Outcome in Schizophrenia Treatment

Hanci N., Eker O. C., Miraloglu O., Uslu M. A., ÖZKAYA G., EKER S. S.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.52, sa.1, ss.64-68, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5152/npa.2015.7041
  • Dergi Adı: NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.64-68
  • Anahtar Kelimeler: Schizophrenia, depression, antidepressant, PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND, DEPRESSIVE SYNDROMES, NEGATIVE SYMPTOMS, SERTRALINE, EFFICACY, SUICIDE, OUTPATIENTS, DISORDERS, EPISODE
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Introduction: Comorbid depression in schizophrenia is associated with poor outcome, increased risk of relapse and a high rate of suicide. Identification of depressive symptoms and their appropriate treatment is crucial for depressed schizophrenic patients. The aim of this study is to investigate the rates of antidepressant prescription and their outcomes.